This complaint was investigated to the extent information was provided to coloplast.Due to the legal nature of this complaint, the device not being returned for evaluation and the implanted device lot number not being provided, a thorough investigation could not be executed.Should additional information become available, this file will be re-evaluated and updated according to current procedures.Complaints of this nature are monitored and captured within the product risk documentation.No further action or corrective action is required at this time.
|
Vaginal discharge, dysuria, uti, sui, vaginitis, difficulty voiding, hematuria, urethral discharge, erosion, urgency, bladder pains, recurrent utis, urinary frequency, nocturia, exposed/eroded vaginal discharge, sui, exposure, mid urinary incontinence, sling excision.As reported to coloplast, though not verified, additional information received on 03/31/2021.Fungal vaginitis and recurrent leakage.On (b)(6) 2017, placement of advantage/fit sling for recurrent sui.Scarring on vaginal mucosa at the level of the midurethra from prior sling removal (altis) is noted.Failed voiding trial and discharged to home with foley catheter.On (b)(6) 2021, c/o of urinary leakage, vaginal pain, dyspareunia, vaginal discharge with odor, dysuria, post void urinary leakage.Trigger point pain in bilateral puborectalis muscles at insertion of tot (altis) sling anchors.No other adverse patient effects were reported.
|